Table 4.
Significant results of general linear model repeated measures analysis of variance test determining the effects of treatment and other independent variables on 1-year changes in positron emission tomography/CT parameters as dependent variables
Dependent variable | Effect | F | P value | Partial η2 |
SUV-SYNmean 0–12 | Treatment * RANKL-0 | 4.619 | 0.046 | 0.214 |
TBR-SYNmean 0–12 | Treatment * RANKL-0 | 11.777 | 0.002 | 0.409 |
TBR-VASCmean 0–12 | Treatment * ESR-0 | 9.899 | 0.006 | 0.368 |
Treatment * DXAL24BMD-0 (inv) | 5.485 | 0.032 | 0.244 | |
TBR-VASCmax 0–12 | Treatment * ESR-0 | 7.535 | 0.014 | 0.307 |
Tretament * DXAL24BMD-0 (inv) | 4.826 | 0.042 | 0.221 |
The numbers -0 and -12 indicate values at baseline and after 12 months of treatment.
BMD, bone mineral density; DXA, dual-energy X-ray absorptiometry; ESR, erythrocyte sedimentation rate; GLM, general linear model; L24, lumbar 2–4 vertebrae; max, maximum; RANKL, receptor activator nuclear factor κB ligand; SUV, standardised uptake value; TBR, target-to-background ratio; VASC, vascular.